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Patients and methods: This retrospective study included 21 patients with clinical and sonographic
signs of acute cholecystitis and comorbid disease who underwent percutaneous cholecystostomy for
management of acute cholecystitis from June 2009 to January 2014.
Results: Percutaneous cholecystostomy was technically successful in 19 patients and showed posi-
tive clinical response at 72 h in 17 patients. Bile leakage due to catheter dislodgement in one patient
was managed by change of catheter and re-insertion. The second patient had partial rupture of gall
bladder, ﬁve patients underwent cholecystectomy. After cholecystostomy there were reductions of
leukocytosis and C – reactive protein.
Conclusion: As an alternative to surgery, percutaneous cholecystostomy is a safe and effective
method of treatment in critically ill patients with acute cholecystitis.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.1. Introduction
Acute cholecystitis is a frequent cause of general surgical admis-
sion with a mortality that is related to the age of the patient (1).
Laparoscopic cholecystectomy is now considered the gold
standard for surgical management of acute cholecystitis (2),yet management of critically ill and complex patients with
acute cholecystitis remains controversial (3).
Surgical options are often unfavorable in patients who are
very unwell or have numerous medical co-morbidities in which
the mortality rates are signiﬁcant (4), morbidity up to 41% (5)
and mortality up to 45% (6) (see Figs. 1–4).
An alternative approach to surgical removal of the gall-
bladder is decompression and systemic antibiotic therapy (4).
Surgical cholecystostomy was ﬁrst described in 1867 (7), but
the ﬁrst percutaneous cholecystostomy for acute cholecystitis
was not performed until 1980 under ultrasound guidance (8).
Percutaneous cholecystostomy is a therapeutic procedure
for decompressing the gall bladder for managing cholecystitis
either deﬁnitively or as a temporizing measure before
cholecystectomy (9).
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of percutaneous cholecystostomy in treatment of acute chole-
cystitis in high risk patients.
2. Patients and methods
Between June 2009 and January 2014 percutaneous cholecys-
tostomy was performed on 21 patients with acute cholecystitis
and comorbid disease in a specialized Hospital in Jeddah-
Saudi Arabia.
Age of patients ranges from 38 to 85 years, median age is
60 years, 15 patients are male and 6 patients are female.
All patients underwent full history taking, physical exami-
nation, laboratory and imaging studies in order to record the
data about comorbid disease, etiology of cholecystitis and
diagnostic criteria for acute cholecystitis and exclusion criteria
for percutaneous cholecystostomy.
Ultrasound was done for all patients and Computed
tomography (CT) for eight patients to exclude other
pathology.
The diagnostic criteria of acute cholecystitis included clini-
cal signs and symptoms (right upper quadrant pain or tender-
ness) leukocytosis or positive C-reactive protein (CRP) value
>5 mg/L and at least one of the ultrasonographic criteria
including gall bladder stones (for calcular cholecystitis) ultr-
asonographic Murphy sign, gall bladder wall thickening
>3 mm, pericholecystic ﬂuid collection and gall bladder dis-
tension (10).
Absolute contraindication includes interposed bowel pre-
venting access to the gall bladder and untreated or severe
bleeding diathesis.
Relative contraindication includes decompressed gall bladder
due to perforation, gall bladder completely packed with calculi
such that a drain cannot be accommodated within it and gall
bladder cancer due to risk of seeding along the track (11).
2.1. Technique
Patients were admitted to the hospital, written informed con-
sent was obtained after fasting for 6–8 h, IV antibiotic (broad
spectrum) was started immediately after diagnosis and subse-
quent antibiotic therapy was managed according to the culture
result of bile.
If coagulopathy is present correction of the condition can be
achieved by transfusion of fresh frozen plasma or platelets or both.
All procedures were performed in the interventional suite
using imaging guidance of ultrasound and ﬂuoroscopy. We
used local anesthesia in most of the cases with or without light
sedation and general anesthesia in two cases.
2.2. Procedure
The gallbladder was identiﬁed with sonogram then puncture
site was chosen.
Under aseptic condition ultrasound guided transhepatic
approach through the right lobe was used to access the gall-
bladder in majority of patients while in two patients we used
ultrasound guided transperitoneal approach.
For local anesthesia, lidocaine 1% was administered in the
subcutaneous tissue along the liver capsule. Two puncture
techniques were used for percutaneous cholecystostomy eitherseldinger technique or trocar needle catheter. The seldinger
technique was the widely used method; it comprised initial
puncture and conﬁrmation of the appropriate position with a
relatively small needle. A wire was then passed to maintain this
position guided, over the guide wire a larger catheter than the
original needle could be passed with track dilation. An 18-
gauge echogenic tip needle (secalon) was used to puncture then
a guide wire (amplaz 0.35) was inserted into the gallbladder
lumen. The route was then dilated using a 6F, 7F or 8F dilator.
Finally a 7F or 8F pigtail catheter was inserted.
The Trocar technique used a simultaneous puncture and
placement of a catheter mounted on a sharp stylet with free
hand technique, sizes of pigtail catheter range from 6F to 8F.
The drainage catheter localization was controlled by ﬂuo-
roscopy through injecting a small amount of contrast. Bile
samples were obtained for micro biological and cytological
analyses and culture sensitivity, the drainage catheter was ﬁxed
to the skin by sutures or adhesive dressing, catheter ﬂushing
with 0.9% saline was performed twice daily to maintain cath-
eter patency.
2.3. Post procedure care
Patients should have bed rest, regular observation for vital
sign monitoring and adequate analgesia for symptoms like
local pain or shoulder discomfort. In patients who had a
difﬁcult procedure and persistent right hypochondrial or
chest pain, a chest radiograph was obtained to exclude
pneumothorax.
On the second day of percutaneous cholecystostomy ultra-
sound examination was performed to check the site of the
catheter, look for bile or blood leakage and size of the gall-
bladder. Laboratory data such as leucocyte count and C-reac-
tive protein were evaluated and repeated after 3 days.
The patient was discharged with the drain in place. The
drain was left in situ during a period of 2 to 3 weeks after
which contrast imaging of the drain will be performed to assess
whether the drain is still located in the gallbladder and whether
there is a patent cystic duct.
A number of factors will affect the timing of catheter
removal such as clinical response and purpose of percutaneous
cholecystostomy (bridge to surgery or deﬁnitive).
Generally, percutaneous cholecystostomy drains are
removed, following a successful trial of drain clamping and
if percutaneous cholecystostomy is to be a deﬁnitive treatment,
the catheter should be replaced every 3 months.
Five patients underwent cholecystectomy, two within
5 days, one after 7 days, one after 12 days and last one after
30 days of cholecystostomy, two laparoscopically and the
other three started laparoscopically then converted to open
due to adhesion.3. Result
Percutaneous cholecystostomy was done for 21 patients. The
median age of treated patients is 60 years (range 38–85 years)
and 15 patients were male (71.4%).
6 patients had acalculous and 15 have calculous
cholecystitis.
Comorbid diseases include congestive heart failure and
severe ischemic heart disease in 5 patients (23.8%), chronic
Fig. 1 A 61 year old man in ICU with acute calcular cholecystitis referred for percutaneous cholecystostomy drainage. (A) Sonogram
shows GB with multiple stones inside. (B) Ultrasound guided drainage after deployment of the catheter and pig tail coiled in the GB. (C)
Cholangiogram obtained via the cholecystostomy catheter shows ﬁlling defect of the stones inside GB and no contrast leakage.
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ure in 3 patients (14.2%), liver cirrhosis in 3 patients
(14.2%), hypertension in 2 patients (9.5%) and diabetes melli-
tus in 6 patients (28.5%).
The procedure was done under local anesthesia for 19
patients (90.5%) and under general anesthesia in 2
patients (9.5%). We used transhepatic approach for 19
patients (90.5%) and transperitoneal approach for 2 patients
(9.5%).
Percutaneous cholecystostomy was technically successful in
19 patients (90.4%) and showed positive clinical response at
72 h in 17 patients (80.9%).
One patient experienced bile leakage on the second day
after the procedure due to catheter dislodgement for which
change of catheter and reinsertion were done and this patientwas considered technically unsuccessful. Five patients under-
went cholecystectomy, 4 of them showed no positive clinical
response within 72 h, 2 underwent the operation within 5 days
of the cholecystostomy due to partial rupture of gall bladder
and the other one developed severe unrelieved right
hypochondrial pain. The third and fourth patients underwent
cholecystectomy after 7 days and 12 days of cholecystostomy.
The last patient underwent elective cholecystectomy after
30 days of cholecystostomy due to recurrence of sign and
symptoms.
One patient experienced mild bleeding at perihepatic area,
no intervention done.
Two patients developed right sided pleural effusion and one
of them needed aspiration which was done. No pneumothorax
developed, no procedure related death occurred.
Fig. 2 A 62 year old man in ICU with distended GB referred for percutaneous cholecystostomy drainage. (A) Sonogram shows
distended gall bladder with thickened wall and sludge. (B) Axial CT abdomen with contrast revealed distended GB, thickened wall and
sludge inside. (C) Ultrasound guided drainage, trocar catheter in the GB. (D) Ultrasound: deployment of the catheter and pig tail coiled in
the GB. (E & F) Cholangiogram obtained via the cholecystostomy catheter to ensure its position and no leakage. CBD stent was seen.
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only bacteria in 7 patients. Enterococcus fecalis, Enterobacter
cloacae, Streptococcus gallolyticus and Proteus mirabilis were
identiﬁed in each of the remaining 4 patients.
The mean white cell count and mean CRP at admission
were signiﬁcantly decreased in the next 72 h in the 17 patients
which showed a positive clinical response.4. Discussion
The treatment of acute cholecystitis in high risk patients is a
much debated subject in the surgical community (5).
Open cholecystectomy, ﬁrst developed by the German Sur-
geon Carl JA Langenbuch was for many years the primary
treatment for symptomatic acute cholecystitis (12).
Fig. 3 A 42 year old man in ICU with distended GB referred for percutaneous cholecystostomy drainage. (A) Axial CT abdomen with
contrast revealed distended and thickened wall GB. (B) Cholangiogram obtained via the cholecystostomy catheter after insertion by
3 weeks revealed a decrease in GB distension, patent cystic and CBD.
Fig. 4 A 67 year old female in ICU with acute choleycystitis referred for percutaneous cholecystostomy drainage. (A) Cholangiogram
obtained via an 18-gauge needle (Secalon) before insertion of drainage pigtail catheter revealed distended GB, stones inside and thickened
wall. (B) Cholangiogram obtained via the drainage catheter after insertion by 3 weeks revealed patent cystic and CBD.
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dard, although generally regarded as a safe operation with a
mortality rate of around 2% (13).
The use of cholecystostomy tube was ﬁrst described as an
option in patients who were critically ill with acute cholecystitis,
it is either placed percutaneously or surgically. Placement of sur-
gically placed cholecystostomy tube laparoscopically offers
many advantages for the surgeon who is considering an attempt
at laparoscopic cholecystectomy, ﬁrst but knows that a surgi-
cally placed cholecystostomy tube can be performed if the
inﬂammation of the gall bladder is too severe (14).
Percutaneous cholecystostomy is deﬁned as an alternative
treatment method in patients with acute cholecystitis who wereat high risk during surgery due to comorbid disease; it repre-
sents a minimally invasive procedure for providing gallbladder
decompression (15).
Gall bladder decompression for the management of chole-
cystitis can be performed as a deﬁnitive therapy in patients
at high risk with medical comorbidities or as temporizing with
measure augmenting medical treatment and preceding a subse-
quent non elective cholecystectomy. The decision of whether to
proceed with cholecystectomy (in surgical candidate) or
consider percutaneous cholecystostomy as a deﬁnitive measure
(in a nonsurgical candidate) is usually multi-disciplinary (i.e.
surgical, anesthesiology and radiology) and depends on
patients’ response to therapy (9).
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sent was gained, broad spectrum antibiotics were prescribed
with a good gram negative cover such as E. coli in the most
commonly cultured pathogen. Signiﬁcant abnormal clotting
should be corrected prior to the procedure and in our experi-
ence review of prior imaging studies are essential to planning
the procedure by helping to determine the access route;
transhepatic or transperitoneal and can highlight difﬁcult or
variant anatomy.
We use ultrasound and ﬂuoroscopy as image guidance for
our patients.
Ultrasound probes used are convex and sector 5–8 MHz
probes, a sector probe is preferable for an intercostal
approach. Catheter position is conﬁrmed using a small volume
of hand injected iodinated contrast medium under ﬂuoroscopic
guidance. A minimal volume of contrast medium should be
injected to minimize distal spread of pathogens and resultant
exacerbation of sepsis.
Ideally the puncture site should be subcostal but if an inter-
costal approach is required, care should be taken to avoid
pleural space and to avoid the intercostal neurovascular bun-
dle passing inferior to the rib.
In our study we use and prefer transhepatic approach, pass
the catheter via the bare area of the liver, which is extra peri-
toneal in order to access the gallbladder. Advantages of this
approach are it reduces the risk of bile leak, provides greater
catheter stability and quicker tract maturation also, it is the
safest method in cases with large ascites and bowel inter posi-
tion between the liver and gallbladder (15).
But there is a higher rate of hepatic bleeding, hemobiliary
ﬁstula and pneumothorax reported from this approach in
many other series (16) but in our study one patient developed
mild perihepatic bleeding which resolved spontaneously within
5 days.
The transperitoneal route is preferable in patients with liver
disease or coagulopathy.
In our experience the trocar puncture technique is prefera-
ble as it reduces the number of steps making it faster and sim-
pler to perform but bleeding risk was high and we found one
patient with bleeding at perihepatic area which resolved
spontaneously.
Advantage of Seldinger technique lies in the relatively small
defect in any structure by the initial needle thereby reducing
the damage to any puncture organ.
In all cases we use locking pigtail catheter drain to ensure
adequate ﬁxation and drainage catheter was ﬁxed to the skin
with suture or adhesive dressing.
In our study infection is not present in all patients. Bile cul-
tures were positive in only 11 (52.3%) of our patients and it is
similar to the frequency mentioned by Joseph et al. 52% (17)
and close to the frequency of 49% described by Chopra
et al. (18).
Percutaneous cholecystostomy was considered technically
successful when the pigtail catheter loop was visualized sono-
graphically and ﬂuoroscopically in the gallbladder lumen and
the gallbladder content would be aspirated freely through per-
cutaneous cholecystostomy catheter.
Positive clinical response was deﬁned as normalization of at
least two of the three clinical parameters of acute cholecystitis
(abdominal pain, fever and leukocytosis) within 72 h.
Inour study technical success happened in19patients (90.4%)
andpositive clinical responsewas achieved in17patients (80.9%).Five patients underwent cholecystectomy , two of them within
5 days of the procedure due to nopositive clinical responsewithin
72 h and complication occurred which necessitates emergency
cholecystectomy. Other two underwent cholecystectomy after
7 days and 12 days due to no positive clinical response. The last
one underwent cholecystectomy after 30 days due to recurrence
of signs and symptoms of cholecystitis.
Major complications in two patients (9.5%) are partial rup-
ture of gallbladder and severe uncontrolled pain for which
emergency laparoscopic cholecystectomy was done.
Chopra et al. (18) reported that percutaneous cholecystos-
tomy was technically successful in 97% and clinical improve-
ment was achieved in 90% and complications occurred in 14%.
Nasim et al. (1) reported (92%) resolution of patient symp-
toms of acute cholecystitis after percutaneous cholecystostomy
by 48 h and reported 31% post procedural complications
including hemorrhage, pneumonia, hypotension and vasovagal
reaction.
Joseph et al. (17) reported 72 patients (68%) showed
improvement clinically whereas 34 (32%) showed no improve-
ment or a clinically worsened condition after cholecystostomy.
5. Conclusion
Percutaneous cholecystostomy is a fast, easy, effective and
technically achievable method for the treatment of cholecysti-
tis with low complication rate even in unwell patients such as
elderly and critically ill.
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